N-heteroarylpiperazinyl Ureas As Modulators Of Fatty Acid Amide Hydrolase


Certain N-heteroarylpiperazinyl urea compounds of Formula (I), as defined in the specification, are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat, e.g., anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders (such as multiple sclerosis).

Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jun 2, 2009
  • Application: Jun 28, 2006
    US US 47812806 A
  • Priority: Jun 28, 2006
    US US 47812806 A
  • Priority: Jun 30, 2005
    US US 69616605 P

Sign in to the Lens